Dexcom (DXCM) EBT Growth (3y) (2013 - 2026)
Dexcom (DXCM) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 17.92% |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | -2.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.85% |
| Mar 31, 2026 | 61.06% |
| Dec 31, 2025 | 36.76% |
| Sep 30, 2025 | 34.07% |
| Jun 30, 2025 | 47.39% |
| Mar 31, 2025 | 62.29% |
| Dec 31, 2024 | 220.80% |
| Sep 30, 2024 | 16.57% |
| Jun 30, 2024 | 24.59% |
| Mar 31, 2024 | 47.49% |
| Dec 31, 2023 | 16.88% |
| Sep 30, 2023 | 47.38% |
| Jun 30, 2023 | 51.07% |
| Mar 31, 2023 | 42.27% |
| Dec 31, 2022 | 12.20% |
| Sep 30, 2022 | 47.24% |
| Jun 30, 2022 | 116.14% |
| Mar 31, 2022 | 49.73% |
| Dec 31, 2021 | 26.75% |
| Sep 30, 2021 | 35.72% |